rs73034295 — IGSF9B IGSF9B Inhibitory Synapse Adhesion

Intronic variant in the gene encoding the inhibitory synaptic adhesion protein IgSF9b, which organizes GABAergic synapses in the centromedial amygdala and modulates anxiety-relevant inhibitory signaling

See your personal result for IGSF9B

Upload your DNA data to find out which genotype you carry and what it means for you.

Upload your DNA data

Works with 23andMe, AncestryDNA, and other DNA test exports. Results in under 60 seconds.

The Amygdala's Brake Circuit — How IgSF9b Shapes Inhibitory Tone and Anxiety

Deep in the temporal lobe, within a structure called the centromedial amygdala (CeM11 CeM
The centromedial amygdala is the primary output hub of the amygdala. It sends projections to the hypothalamus and brainstem that drive fear responses, stress hormones, and autonomic nervous system activation), a protein called IgSF9b quietly organizes the machinery that keeps anxiety in check. This protein, encoded by the IGSF9B gene on chromosome 11, acts as a scaffold at GABAergic inhibitory synapses22 GABAergic inhibitory synapses
Synapses that use gamma-aminobutyric acid (GABA) as their neurotransmitter. GABA is the brain's main inhibitory signal — it reduces neuronal excitability and counterbalances excitatory glutamate signaling, helping to calibrate how strongly the amygdala can be suppressed when fear circuits need to be quieted. The rs73034295 A allele sits within an intron of IGSF9B and has been identified as a genome-wide significant locus for educational attainment and cognitive processing speed — traits that share deep genetic architecture with anxiety and inhibitory neural function.

The Mechanism

IgSF9b belongs to the immunoglobulin superfamily of cell adhesion molecules. Unlike its role in immune cells, in the brain it functions as a trans-synaptic organizer33 trans-synaptic organizer
A protein that bridges the gap between two neurons at a synapse and coordinates the assembly of pre- and postsynaptic molecular machinery on both sides, specifically at inhibitory synapses of the centromedial amygdala. It works in opposition to another synaptic adhesion protein, Neuroligin-2, which organizes inhibitory synapses in the neighboring basal amygdala.

The logic of this circuit is counterintuitive but well-supported: IgSF9b's presence at CeM synapses appears to constrain inhibitory transmission. When IgSF9b is deleted in mouse models, the result is paradoxical — GABAergic inhibitory currents in the CeM actually increase, mIPSC (miniature inhibitory postsynaptic current44 miniature inhibitory postsynaptic current
The electrical signal recorded in a neuron when a single vesicle of GABA is released at a synapse. Measuring mIPSCs reveals how many functional inhibitory synapses are active and how sensitive the postsynaptic neuron is to GABA) frequency goes up, and VIAAT-positive (vesicular inhibitory amino acid transporter55 vesicular inhibitory amino acid transporter
The protein that packages GABA into synaptic vesicles. More VIAAT puncta means more active inhibitory release sites) synaptic contacts increase in perisomatic regions of CeM neurons. More inhibition at the CeM output nucleus means the amygdala's anxiety drive is more effectively suppressed. This is why IgSF9b deletion produces an anxiolytic (anxiety-reducing) phenotype.

The rs73034295 A allele is intronic, so it does not change the IgSF9b protein directly. It likely acts as a regulatory variant affecting IGSF9B expression levels or splicing efficiency, particularly in brain tissue. This mechanism is consistent with the GWAS signal for cognitive processing speed, which Li et al. 2024 mapped to postsynaptic membrane biology — precisely the compartment where IgSF9b operates.

The Evidence

The foundational mechanistic work comes from Babaev et al. 201866 Babaev et al. 2018
Babaev O et al. IgSF9b regulates anxiety behaviors through effects on centromedial amygdala inhibitory synapses. Nature Communications, 2018. who demonstrated in mice that local knockdown of IgSF9b specifically within the adult CeM produced "a prominent anxiolytic effect" in open-field and elevated plus-maze tests. Critically, this effect was region-specific: manipulating IgSF9b in the basal amygdala produced no anxiety change, confirming the CeM circuit as the relevant locus. The authors propose that "IgSF9b-expressing synapses in the CeM may represent a target for anxiolytic therapies."

At the human genetics level, three independent large-scale GWAS have identified rs73034295-A as genome-wide significant. The Lee et al. 2018 educational attainment GWAS77 Lee et al. 2018 educational attainment GWAS
Lee JJ et al. Gene discovery and polygenic prediction from a genome-wide association study of educational attainment in 1.1 million individuals. Nature Genetics, 2018. first identified the association (p=2×10⁻⁸, beta=0.0099 SD units). The signal was replicated and strengthened in the Okbay et al. 2022 study of 3 million individuals88 Okbay et al. 2022 study of 3 million individuals
Okbay A et al. Polygenic prediction of educational attainment within and between families from genome-wide association analyses in 3 million individuals. Nature Genetics, 2022. (p=4×10⁻¹³). A 2024 GWAS of cognitive processing speed by Li et al.99 Li et al.
Li M et al. Cognitive processing speed and accuracy are intrinsically different in genetic architecture and brain phenotypes. Nature Communications, 2024. independently identified rs73034295 (p=6×10⁻¹⁰) and attributed the locus to postsynaptic membrane function — consistent with IgSF9b's role as a postsynaptic adhesion organizer.

The A allele is notably rare in East Asian (~2%) and African (~4%) populations but reaches ~20% frequency in Europeans, where the GWAS signals were predominantly detected. This population stratification should be considered when interpreting the findings.

Practical Implications

The actionable angle for A allele carriers centers on supporting the GABAergic inhibitory system — the exact pathway that IgSF9b normally modulates. Nutrients and practices that enhance GABA synthesis and receptor sensitivity, or that reduce hyperactivation of the amygdala's fear output circuits, are particularly relevant. Because the evidence is primarily mechanistic (animal models and GWAS associations with cognitive traits), actions are calibrated accordingly, with emerging-to-moderate evidence levels.

Carriers also benefit from understanding that their cognitive processing may operate slightly differently. The educational attainment GWAS association is very small in effect size (beta ~0.01 SD), meaning it explains a negligible fraction of cognitive variance — but it points to underlying synaptic biology that can be meaningfully influenced by environment and targeted supplementation.

Interactions

IgSF9b works in functional opposition to Neuroligin-2 (NLGN2) in the amygdala circuit. NLGN2 organizes inhibitory synapses in the basal amygdala, while IgSF9b constrains inhibition in the centromedial amygdala. Babaev et al. 2018 demonstrated that IgSF9b deletion rescues the anxiety phenotype of NLGN2-knockout mice — meaning the two proteins counterbalance each other. Variants in NLGN2 could interact with rs73034295 to compound or cancel out effects on amygdala inhibitory tone, though no human compound genotype studies exist yet.

The GABAergic pathway also connects to the broader HPA axis stress response. Variants in FKBP5 (rs1360780), which governs glucocorticoid receptor sensitivity and interacts with childhood stress to predict anxiety outcomes, may amplify or dampen the downstream consequences of altered CeM inhibitory tone.

Genotype Interpretations

What each possible genotype means for this variant.

GG Standard Inhibitory Tone Normal

Normal IgSF9b expression and CeM inhibitory synapse function

The GG genotype means IGSF9B is expressed at its baseline level, and the IgSF9b protein is expected to organize GABAergic synapses in the centromedial amygdala normally. The educational attainment and cognitive processing GWAS findings do not apply to this genotype. The mechanistic animal work by Babaev et al. 2018 describes a system where IgSF9b constrains CeM inhibitory transmission — in GG individuals, this constraint is operating without the potential reduction associated with the A allele. No specific genetic action is warranted.

AG One Copy — Mild Effect Intermediate

One A allele — subtle reduction in IgSF9b inhibitory synapse scaffolding

Heterozygous AG carriers have one functional copy of IGSF9B from the G allele and one A allele that may reduce expression or alter splicing in brain tissue. Because IgSF9b constrains GABAergic inhibitory transmission in the centromedial amygdala, reduced IgSF9b scaffolding could shift the balance of amygdala output toward slightly less effective inhibitory suppression of anxiety-relevant circuits. The human GWAS associations are in the direction of reduced cognitive processing efficiency with the A allele. While the per-SNP effect on any individual's anxiety level is small, the biology identified provides a clear mechanistic rationale for supporting GABAergic tone through targeted means.

AA Two Copies — Stronger Effect High Risk

Two A alleles — stronger reduction in IgSF9b inhibitory synapse function

AA homozygotes carry two A alleles at rs73034295, both potentially reducing IGSF9B expression or splicing efficiency in brain tissue. In the educational attainment GWAS (Okbay et al. 2022, N=3 million), the additive effect corresponds to approximately twice the per-allele beta. The GWAS for cognitive processing speed (Li et al. 2024) mapped this locus to postsynaptic membrane function — exactly where IgSF9b operates as an inhibitory synapse scaffold. While the individual GWAS effect sizes are small, the biological context is clear: the CeM inhibitory circuit is mechanistically relevant to anxiety, as demonstrated by the prominent anxiolytic effect of IgSF9b CeM knockdown in adult mice (Babaev et al. 2018). AA carriers have the strongest rationale among IGSF9B genotypes for targeted support of GABAergic inhibitory function.